Fifth INTERMACS annual report: risk factor analysis from more than 6,000 mechanical circulatory support patients

J Heart Lung Transplant. 2013 Feb;32(2):141-56. doi: 10.1016/j.healun.2012.12.004.


The 5th annual report of the Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) summarizes and analyzes the first 6 years of patient and data collection. The current analysis includes more than 6000 patients and updated risk factors for continuous flow pumps. Among continuous flow pumps, actuarial survival is 80% at 1 year and 70% at 2 years. Quality of life indicators are generally favorable and adverse event burden will likely influence patient selections of advanced heart failure therapies.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Adult
  • Annual Reports as Topic
  • Assisted Circulation / instrumentation*
  • Equipment Design
  • Heart Failure / complications
  • Heart Failure / therapy*
  • Heart-Assist Devices* / statistics & numerical data
  • Humans
  • National Institutes of Health (U.S.)
  • Quality of Life
  • Registries*
  • Renal Insufficiency / complications
  • Risk Factors
  • United States
  • Ventricular Dysfunction, Right / complications